Umoja Biopharma appoints Britton Russell as CFO with experience scaling life science organizations.

Umoja Biopharma, a company developing off-the-shelf immunotherapies, has appointed Britton Russell as its new Chief Financial Officer. Russell brings experience from both emerging growth companies and large multinationals. His expertise in scaling life science organizations will be crucial as Umoja aims to bring its first VivoVec drug candidates to the clinic in 2024.